Flindix

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flindix

Quick Facts

Property Description
Active ingredient Isosorbide Dinitrate (ISDN)
Form Tablet (oral, sublingual), Capsule (extended-release)
Pharmacological class Vasodilator, Antianginal Agent
General purpose Reduction of cardiac workload
Origin Synthetic organic nitrate

What Type of Medicine is Flindix?

Flindix is a trade name for the active drug component, Isosorbide Dinitrate (ISDN), which is a synthetic organic nitrate primarily utilized in cardiovascular care. It is officially categorized by medical nomenclature as a potent Vasodilator and an Antianginal Agent. This classification defines its fundamental pharmacological role as a medicine that actively causes the widening of blood vessels. The compound is synthetic, prepared from sorbitol, and is classified chemically as a nitrate ester. As a single-ingredient product, Flindix is focused solely on delivering the therapeutic effects of Isosorbide Dinitrate to the systemic circulation.

Flindix: Composition and General Function

The composition of this medication centers on the pure Isosorbide Dinitrate (ISDN), which is formulated with pharmaceutical excipients to create various stable dosage form(s). These forms include the standard oral tablet, the specialized sublingual tablet (taken under the tongue), and the extended-release capsule. The key differentiating factor here is the sublingual tablet, allowing for rapid absorption, which provides a fast onset of effect when required. The general function of Flindix is to reduce the overall workload of the heart. It operates as a nitric oxide donor, causing the relaxation of vascular smooth muscle, which results in broad vasodilation. This action primarily reduces the return of blood to the heart (preload), decreasing the effort the heart must exert. This fundamental effect of easing cardiac strain is a typical, neutral use scenario for patients needing sustained support for the cardiovascular system.

Regulatory References

  1. Isosorbide: MedlinePlus Drug Information

What side effects are possible with Flindix?

Possible Side Effects and Safety Information: Flindix

Flindix (Isosorbide Dinitrate) is associated with an official safety profile primarily characterized by its potent vasodilating properties. Most common adverse reactions are related to this mechanism of action.

Adverse Reactions

Side effects are often categorized by system-organ class. Reactions affecting the Nervous System commonly include headache, which may be severe, and dizziness. Effects on the Cardiovascular System are significant and may include hypotension (low blood pressure) and tachycardia (increased heart rate).

Classification Examples of Adverse Reactions
Cardiovascular Hypotension, Tachycardia, Syncope
Nervous System Headache, Dizziness
Hemic System Methemoglobinemia (Rare, Serious)

Serious and Clinically Significant Risks

Serious adverse reactions documented in regulatory sources include severe hypotension leading to cardiac collapse and syncope (fainting). A rare but serious risk is methemoglobinemia, which can impair the blood's ability to carry oxygen. Overexposure or overdose is specifically linked to these severe vasodilatation effects, potentially causing convulsions and coma.

Safety Considerations and Restrictions

Flindix is contraindicated (should not be used) in patients with known hypersensitivity to nitrates, pre-existing conditions like marked anemia, head trauma, or cerebral hemorrhage. Use is also restricted in situations that increase the risk of severe hypotension or methemoglobinemia, such as with certain co-administered drugs. Patients should be monitored for signs of hypotension and methemoglobinemia during treatment, as described in official labeling.

Overdose and Emergency Response

The official regulatory documentation describes an overdose of Flindix (Isosorbide Dinitrate) as an acute event that results from an exaggeration of its effects. Immediate medical attention must be sought if an overdose is suspected, as severe manifestations may be life-threatening.

Overdose presentations frequently involve a prompt fall in blood pressure, resulting in symptoms such as persistent and throbbing headache, vertigo, palpitation, and syncope (fainting). Gastrointestinal manifestations may include nausea, vomiting, and in some cases, bloody diarrhea. Severe, life-threatening outcomes documented include profound circulatory failure, convulsions, and coma. A rare but serious complication is Methaemoglobinaemia, a condition requiring specific treatment (Methylene blue).

If acute overdose occurs, official guidance states that the patient should be admitted to a medical facility for structured management. This care is symptomatic and supportive, as no specific antagonist to the primary vasodilator effects is known. Procedures may include gastric aspiration or lavage, along with the administration of oxygen and intravenous fluids to manage severe hypotension. Vital signs, blood pressure, and cardiac function must be continuously monitored. Special consideration is noted for patients with underlying cardiovascular disease, renal failure, or congestive heart failure.

Therapeutic Uses of Flindix

What Flindix Treats: Main Uses and Benefits

Flindix (Isosorbide Dinitrate) is a prescription medicine generally used for its therapeutic benefits in managing symptoms related to cardiovascular strain. The therapeutic benefits of the medication correspond to the established pharmacological properties of its active ingredient.

Symptom Management and Prophylaxis

The medication is commonly used across conditions presenting with episodic or fluctuating manifestations, relevant for the long-term prophylaxis and maintenance therapy of Angina Pectoris associated with Coronary Artery Disease. It is also relevant for easing the overall symptom load in conditions characterized by periods of heightened symptoms, such as Chronic Heart Failure. It assists in managing symptoms related to systemic imbalance, such as shortness of breath or respiratory distress.

Quick Fact: Management of Chest Discomfort Symptoms
Prophylactic Use Recurrent Angina Attacks
Supportive Symptom Management Pulmonary Congestion Symptoms

The medication is applied across domains where additional symptomatic support is needed to help patients cope more steadily with symptom fluctuations. It is commonly used when short-term symptomatic assistance is needed, such as in scenarios where symptoms are predictably triggered by physical exertion or emotional stress. This supports general well-being during symptomatic phases and assists with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Flindix?

The population eligibility for Flindix (Isosorbide Dinitrate) is strictly defined by regulatory documents, establishing patient groups who must not use the medicine and those who require careful consideration.

Absolute Contraindications

Flindix is contraindicated and must not be used in the following populations:

  • Patients with a known hypersensitivity or allergy to isosorbide dinitrate or any other organic nitrates.
  • Patients taking Phosphodiesterase type 5 (PDE5) inhibitors (e.g., sildenafil, tadalafil) or the soluble guanylate cyclase (sGC) stimulator riociguat.
  • Patients presenting with circulatory collapse, cardiogenic shock, marked anaemia, or conditions associated with increased intracranial pressure.

Age and Condition Restrictions

Flindix is primarily intended for use in adults.

Population Group Regulatory Status
Pediatric Patients (Under 18) Safety and effectiveness have not been established in this age group.
Older Adults (65 years and over) Use requires caution due to a greater frequency of decreased hepatic, renal, or cardiac function.
Pregnancy Use is categorized as Pregnancy Category C; permitted only if the potential benefit justifies the potential risk to the fetus.
Lactation Caution should be exercised, as it is not known if the drug is excreted in human milk.

Use also requires caution in patients with severe hepatic impairment, renal insufficiency, volume depletion, or severe hypotension.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations

Regulatory documents formally prohibit co-administration with certain medicinal product categories due to the risk of severe, life-threatening hypotension and cardiovascular collapse. This restriction is classified as an absolute contraindication.

Substances Prohibited for Co-use:

  • Phosphodiesterase Type 5 (PDE5) Inhibitors: This includes specific agents like sildenafil, tadalafil, vardenafil, and avanafil.
  • Soluble Guanylate Cyclase (sGC) Stimulators: This includes the medicine riociguat.

Pharmacodynamic and Exposure Interactions

Flindix (Isosorbide Dinitrate) has a documented pharmacodynamic interaction with other agents that lower blood pressure, which may lead to an additive hypotensive effect.

  • Blood Pressure Lowering Agents: This includes classes such as beta-blockers, calcium channel blockers, ACE-inhibitors, and other vasodilators.
  • Alcohol (Ethanol): The use of alcohol may potentiate the hypotensive and vasodilating effects, a risk documented in official labeling.
  • Ergot Derivatives: Flindix may increase the blood level and potential effects of certain ergot derivatives, such as ergotamine and dihydroergotamine, by decreasing their metabolism.

Mandatory Timing Rules

Specific time-separation requirements are mandatory for acute administration of Flindix following the use of certain prohibited medicines. Acute therapy must not be used within 24 hours after the last dose of sildenafil or vardenafil, and 48 hours after the last dose of tadalafil. These administration constraints are established to allow for clearance of the interacting agent.

Mechanism of Action

Bioactivation and the Nitric Oxide Cascade

Isosorbide Dinitrate acts as a prodrug that is bioactivated by the mtALDH enzyme within vascular smooth muscle cells, releasing Nitric Oxide (NO). NO then activates the enzyme soluble Guanylate Cyclase (sGC), triggering the production of the second messenger, cGMP. This cascade is the primary mechanism initiating cellular relaxation.


Modulating Vascular Tone and Preload

The accumulation of cGMP drives the final cellular effect: the relaxation of vascular smooth muscle. This action is most pronounced in the systemic veins, causing vessel widening and significantly increasing venous capacitance. This physiological change fundamentally results in a redistribution of blood volume, which decreases the volume of blood returning to the heart, effectively reducing cardiac preload and subsequent wall tension on the myocardium.


️ Mechanism Limitations: Tolerance and Constraint

The maintenance of the drug's effect is dependent on the consistent function of the bioactivation pathway. Continuous exposure can deplete necessary cofactors (thiol groups) required for the mtALDH enzyme to release NO, leading to pharmacodynamic tolerance (tachyphylaxis). This constraint means the drug's mechanism is physiologically limited and requires periods of non-exposure to regain responsiveness.

Dosage and Administration Information

How to Use Flindix: Official Administration Guidelines

Flindix (Isosorbide Dinitrate) is administered through specific routes and schedules as established for the medication. The medication is used either orally for maintenance therapy or sublingually for prompt administration in certain scenarios.


Administration Routes and Scheduling

Administration Route Standard Dosing Frequency Key Procedural Requirement
Oral (Immediate-Release) Two or three times a day Must be scheduled to include a daily nitrate-free interval
Oral (Extended-Release) Typically once daily Capsule or tablet must be swallowed whole (do not crush or chew)
Sublingual As-needed or 15 minutes before activity Place tablet under the tongue and allow to dissolve

Official Dosing and Use Patterns

The fundamental principle of long-term use is the requirement for a dose-free period to prevent pharmacological tolerance. Immediate-release regimens are structured to incorporate a daily nitrate-free interval of at least 14 hours to maintain effectiveness.

Therapy generally starts at a low dose, typically 5 mg to 20 mg for the immediate-release oral form, and is gradually increased to a maintenance range, which can extend up to 40 mg two or three times daily. The sublingual form is typically used in doses of 2.5 mg to 5 mg. For older adults, treatment is initiated at the low end of the standard dosing range due to potential sensitivity. The medicine may be taken with or without food.

If a dose of the maintenance form is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped; two doses must not be taken together.

Recent Clinical Evidence

Research evidence / Overview of studies for Flindix


Evidence for the Management of Stable Angina Pectoris

Flindix (Isosorbide Dinitrate) was studied for the management of stable angina pectoris, a condition characterized by fluctuating or episodic manifestations of chest discomfort. Research primarily relies on short- to intermediate-term Randomized Controlled Trials (RCTs). These studies were designed to explore how the medicine compares to an inactive substance or other treatments. Researchers examined outcomes related to physical discomfort, mainly by tracking the weekly number of anginal episodes that patients reported.

Studies monitored outcomes reflecting daily functioning or activity level, specifically the change in the patient’s ability to exercise for a duration on a treadmill before chest pain began. Research reports on the change in exercise duration when compared to placebo in single-dose assessments. A key focus is addressing the development of drug tolerance. Studies monitored the development of tolerance, where the observed effect on exercise capacity can diminish when administered continuously without interruption. Studies explored the use of intermittent or modified administration schedules.


Evidence as Adjunctive Therapy in Chronic Heart Failure

Flindix was studied for its role as an adjunctive treatment for Chronic Heart Failure (CHF). The research base includes major long-term RCTs that explored the use of Flindix in combination with other heart medicines, such as hydralazine. These trials monitored major clinical outcomes, such as all-cause mortality and the frequency of hospitalization for heart failure-related events.

Research describes patterns observed in one key trial, which focused on African American patients with moderate to severe heart failure, noting that the specific combination with hydralazine was associated with changes in mortality and hospitalization rates. Certainty remains low regarding the use of Flindix (the single ingredient) used alone for improving long-term survival in the general CHF population, as key outcomes research primarily involved the fixed-dose combination product. Findings from the specific African American cohort may not directly reflect outcomes for all other groups.


What Is Still Uncertain or Under Research

For stable angina, a significant limitation is the frequent development of tolerance over time with continuous use, and research is ongoing to find the most effective strategies to manage this. The most compelling evidence for long-term major outcomes in CHF is heavily tied to the fixed-dose combination, meaning comparative evidence is lacking for Flindix (the single ingredient) used alone in broader patient groups. Additionally, data are still emerging for its use in patients with heart failure where the pumping function is preserved.

Key Studies & References

  1. Isosorbide Dinitrate (ISDN) Monograph: General Drug Information

Frequently Asked Questions (FAQ)

Common questions about Flindix (FAQ)

Q: Is Flindix the same type of medicine as [similar drug name]?

According to official product information, Flindix (Isosorbide Dinitrate) is classified as a Vasodilator and an Organic Nitrate. This places it in the category of antianginal agents. Other medicines may share this classification, but the specific details of their use and formulation will vary.

Q: Why is Flindix used for condition X when it's also known for condition Y?

Flindix is indicated for the prevention of angina pectoris (chest pain) and is also approved as part of a fixed combination to treat chronic heart failure. This versatility is related to the drug's core mechanism, which is reducing the overall workload on the heart.

Q: Can Flindix cause weight gain or weight loss?

Official labeling for this class of medicine has reported weight gain as a less common adverse reaction. Significant weight loss is generally not listed among the commonly reported side effects linked to Flindix.

Q: How long does it usually take to feel the effects of Flindix?

The time it takes to feel the effect depends on the form used. The sublingual tablet is intended for prompt use and often provides antianginal activity in a few minutes. The oral tablet is used for daily prevention (maintenance) and typically begins its effect about one hour after it is taken.

Q: Does Flindix stay in your system for a long time?

While the active component has a short half-life of about one hour, the body processes it into other active compounds (metabolites) that remain in the body longer. This clearance profile is the basis for the mandatory daily nitrate-free interval—often 14 hours—required to maintain the drug’s effectiveness.

Q: Is it okay to use Flindix with common over-the-counter pain relievers?

Official drug interaction warnings focus mainly on prescription medications that lower blood pressure, as well as certain medicines for erectile dysfunction. The label notes that all co-administered drugs, including non-prescription pain relievers, should be reviewed by a prescribing professional.

Q: Does Flindix interact with birth control pills?

Authoritative sources, such as the UK's National Health Service, indicate that Flindix (Isosorbide Dinitrate) will not stop any type of hormonal contraception from working. This information is provided for educational purposes only and should not replace professional medical assessment.

Q: Is Flindix safe to use for older adults?

Use in older adults requires caution according to regulatory documents, as this age group may experience decreased kidney, liver, or heart function more frequently. For this reason, regulatory documents state that treatment regimens are typically initiated at the lower end of the standard dosing range.

Q: Do you need a special diet when using Flindix?

Official product information states that the medicine may be taken with or without food. No special diet is mandated, but a high-fat meal may slightly affect absorption. The labeling does indicate avoiding or limiting alcohol due to the risk of an additive effect in lowering blood pressure.

Q: Is there a generic version of Flindix available yet?

Yes, the active ingredient in Flindix, Isosorbide Dinitrate (ISDN), is widely available as a generic product. Generic versions are offered in immediate-release and extended-release forms.

Q: Can Flindix affect my sleep schedule?

While the primary reported effects are headache and dizziness (nervous system effects), some patient information sources note that trouble sleeping (insomnia) has been reported as a less common side effect.

Q: Is it true that Flindix can affect liver function?

The official labeling does not state that Flindix causes liver damage. However, regulatory documents advise using the medicine with caution in patients who already have severely impaired hepatic (liver) function.

Q: What does the official patient leaflet say about driving while using Flindix?

Because Flindix can cause side effects like dizziness and fainting (syncope), the official label contains warnings about operating machinery, stating that this activity should be avoided if these side effects occur.

Q: What does the research say about the long-term use of Flindix?

Studies on continuous use of Flindix show that patients can develop pharmacological tolerance, meaning the antianginal effect may decrease over time. To address this constraint, dosing schedules are structured to include a daily dose-free interval.

Q: Is Flindix an addictive medicine?

Regulatory documents, particularly from cases of high-dose industrial exposure, have reported signs of physical dependence upon sudden discontinuation. This confirms a potential for physical dependence, where withdrawal symptoms (such as increased chest pain) may occur if the medicine is stopped abruptly.

Q: Why do some people report feeling nauseous when they first start Flindix?

Official reports and clinical sources list nausea and vomiting among the potential side effects that occur with the use of Flindix. These effects are typically categorized as less common, often reported when treatment begins.

Q: How does Flindix compare generally to other medicines for the same condition?

Flindix belongs to the nitrate-class vasodilator group. Its core action is described as similar to nitroglycerin, another nitrate, but its slower onset of action makes it generally more suitable for long-term prevention (prophylaxis) of angina rather than immediate relief.

Q: Is Flindix a steroid?

No, Flindix is not a steroid. It is chemically classified as a synthetic organic nitrate and a nitric oxide donor, used to widen blood vessels and ease the heart's workload.

Q: Can Flindix be split or crushed?

Official guidelines state that extended-release forms must be swallowed whole and should not be crushed or chewed. The immediate-release and sublingual forms have specific administration methods that relate to their purpose.

Q: What happens if I stop using Flindix suddenly?

Regulatory documents warn that the abrupt discontinuation of Flindix, particularly after long-term, continuous use of high doses, has been associated with a potential for increased anginal attacks and withdrawal symptoms.

Q: Does Flindix have a Black Box Warning, and what does it mean?

The single-ingredient drug Flindix does not carry a Black Box Warning. However, regulatory information shows that a specific fixed-dose combination product containing Flindix has carried this warning related to its approved use in treating heart failure in a specific patient population.

Q: Can I use Flindix if I have a history of heart problems?

Flindix is indicated to treat certain heart conditions, such as angina and chronic heart failure. Conversely, official documents contraindicate its use in patients with specific, severe heart issues, including circulatory collapse, shock, or severe low blood pressure.

Q: Why are clinical trials important for Flindix?

Clinical trials are the essential regulatory method used to establish the safety (by tracking adverse events) and efficacy (by measuring patient outcomes like exercise tolerance) of Flindix before it is approved and prescribed.

Q: Is Flindix associated with any mental health side effects?

Official adverse reaction listings primarily focus on physical nervous system effects like headache and dizziness. Common mental health effects such as depression, anxiety, or mood changes are not explicitly listed in the Adverse Reactions tables of regulatory documents.

Q: How is Flindix removed from the body?

Flindix is removed from the body through a process called metabolism. This process primarily takes place in the liver, where the drug is broken down (denitrated) into various active and inactive compounds, which are then cleared from the body.

Q: What does the drug label say about using Flindix during pregnancy?

Official labeling places Flindix in Pregnancy Category C. This classification is a regulatory statement meaning that use is permitted only if the potential benefit justifies the potential risk to the fetus, as determined by the prescribing professional.

Q: What if Flindix doesn't seem to be working for me after a few weeks?

Official patient information indicates that a diminished effect may be a sign of tolerance developing. To maintain the medicine's effectiveness, the importance of following the dosing regimen, particularly the required nitrate-free interval, is highlighted in the product label.

Q: Does taking Flindix at a specific time of day make a difference?

Regulatory regimens are designed to achieve a required daily nitrate-free interval of approximately 14 hours. This typically means scheduling the doses to ensure the non-exposure period occurs during the evening or night hours.

Q: Is Flindix used to prevent a condition or to treat active symptoms?

Flindix is primarily indicated for the prevention (prophylaxis) of angina pectoris, and its oral forms are used for this purpose. However, the sublingual form is specifically designed for rapid absorption and can be used for acute symptoms or anticipation of an attack.

Q: Are there specific vitamins or supplements that interact with Flindix?

Official interaction lists focus on prescription drugs and alcohol. Some patient information sources mention that supplements like Vitamin C have been studied for their potential to help prevent tolerance, but official labeling does not mandate or recommend their use.

Q: Is Flindix available without a prescription in any country?

No. Based on international drug classifications, Flindix (Isosorbide Dinitrate) is officially classified as a prescription medication (Rx-only) and is not available for purchase over the counter globally.

How should Flindix be stored and disposed of?

How to Store and Dispose of Flindix

Flindix (Isosorbide Dinitrate) must be stored and disposed of according to official regulatory requirements to ensure its stability and prevent accidental harm.

Storage Conditions

Flindix must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medicine must be protected from light and moisture and should be kept in the original container, which must be kept tightly closed. Do not freeze this medicine. As a mandatory safety measure, Flindix must always be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Flindix should not be discarded in household trash or flushed down the toilet, unless specifically advised by official labeling. Disposal must be handled through an official drug take-back program or by following the instructions of a pharmacist or local waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flindix found in:

A-Z Index: